Nicole Sandford was appointed to Board of Aspira Women's Health (NASDAQ:AWH) in February 2021 and has served as President and Chief Executive Officer since March 2022. Nicole brings more than three decades of executive and leadership experience to the role as an innovator, business leader and sought-after advisor to CEOs and Boards on strategy, operations, human capital, governance, and risk. She spent over 27 years with global consultancy, Deloitte, where she launched new ventures, transformed underperforming practices, and led mature businesses, including the firm's flagship Regulatory and Operational Risk practice. She started her career with Deloitte as an auditor specializing in high-growth global companies in the technology, healthcare and industrial sectors, and advising on complex transactions including mergers and acquisitions, financings, and securities offerings. Nicole is a member of the Advisory Board for Ellig Group, a boutique human capital and strategy consultancy, an Emeritus Member of the Weinberg Center at the University of Delaware and the patient representative for the Greenwich Hospital Breast Cancer Accreditation Committee. She was previously the Board Chair of Girl Scouts of Connecticut, and Board Member of the Stamford Public Education Foundation.